Capital One Financial put/call ratio hit 1.26 on May 19 — 3.8 standard deviations above its 20-day mean of 1.01. That's the loudest options signal the stock has generated in months, and it's arriving with two other data streams moving in the same direction.
The PCR reading of 1.26 sits well above the 20-day baseline. For context, the 52-week range runs from 0.69 to 1.51 — so today's print is near the upper quartile. Demand for put protection has intensified sharply across just four trading days. On May 15, the PCR was 0.98 — essentially neutral. By May 19, it had spiked to a multi-week extreme.
July 23 is the next scheduled earnings date. With the stock down 9.3% over the past month, options traders are loading up on downside protection well in advance.
SI % of float remains modest at 1.38%. But the rate of change matters here. Short positions grew 13.9% in a single week. That's the fastest build in the 30-day window captured in the data.
Cost to borrow jumped 191% week-on-week, reaching 0.42%. The absolute level is still low. But a near-tripling of borrow cost in five days points to sudden incremental demand — consistent with fresh short positioning rather than existing holders sitting still.
Borrow supply remains ample. Availability is deep, so the CTB move reflects demand pressure, not supply constraints.
Wall Street stays constructive. The consensus is Buy, with Overweight ratings from Barclays, Morgan Stanley, Wells Fargo, and Goldman Sachs all on record. Barclays actually raised its target to $250 after last month's earnings. But other firms trimmed: Goldman cut from $300 to $260, Morgan Stanley from $300 to $273, Truist from $275 to $255.
The pattern is consistent — conviction on direction, less conviction on magnitude. The stock trades at $187 against a field of targets clustered between $213 and $273. That gap may be part of why put buyers are active: the stock has already given back ground, and the next catalyst is two months away.
The stock's last two earnings prints both saw declines. April 2026 delivered a –4.0% one-day move and –4.1% over five days. The prior event: –3.1% on the day, –6.6% over five days.
Three converging reads — elevated PCR at a 3.8-sigma extreme, a 14% weekly short interest build, and a CTB spike — all arrived within a four-day window. The next inflection point is Q2 earnings on July 23. Watch whether the put/call ratio sustains above 1.20, and whether short interest continues building toward the 2% level.
Key data (as of May 18–19, 2026)
See the live data behind this article on ORTEX.
Open COF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
